RNA Review Time
RNA's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.
Senior Researcher, Molecular & Cell Biology
Author context
Specializes in molecular and cell biology manuscript preparation, with experience targeting Molecular Cell, Nature Cell Biology, EMBO Journal, and eLife.
What to do next
Already submitted to RNA? Use this page to interpret the status and choose the next step.
The useful next step is understanding what the status usually means at RNA, how long the wait normally runs, and when a follow-up is actually reasonable.
RNA review timeline: what the data shows
Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.
What shapes the timeline
- Desk decisions are fast. Scope problems surface within days.
- Reviewer availability is the main variable after triage. Specialized topics take longer to assign.
- Revision rounds reset the clock. Major revision typically adds 6-12 weeks per round.
What to do while waiting
- Track status in the submission portal — status changes signal active review.
- Wait at least the journal's stated median before sending a status inquiry.
- Prepare revision materials in parallel if you expect a revise-and-resubmit decision.
Quick answer: RNA review time is relatively efficient for a specialist society journal. Current publisher materials say authors can anticipate rapid decisions and publication, with a current average time from submission to final acceptance of 93 days. That is about 3.1 months. Public article histories show real variation around that average, but the overall message is clear: RNA is not trying to trap papers in a sprawling review cycle. The main timing variable is whether the manuscript is truly RNA-centered from the first editorial read.
RNA timing signals at a glance
Metric | Current value | What it means for authors |
|---|---|---|
Official average submission to final acceptance | 93 days | A practical planning range of about 3.1 months |
Official editorial posture | Rapid decisions and publication | The journal is built for a relatively efficient specialist workflow |
Handling-editor model | 19 active handling editors | Specialist oversight can improve reviewer matching |
Official process claim | Editors engage with authors to expedite revision and re-review | The journal is trying to reduce avoidable delay |
Example article history 1 | 60 days from receipt to acceptance | Clean cases can move faster than the average |
Example article history 2 | 140 days from receipt to acceptance | Harder cases can still take materially longer |
Impact Factor (JCR 2024) | 5.0 | Strong specialist journal rather than a broad prestige gate |
5-year JIF | 4.7 | Stable, mature field journal citation profile |
Resurchify SJR | 2.512 | Solid Scopus prestige inside molecular biology |
Resurchify h-index | 196 | Deep specialist archive with long-lived field influence |
That 93-day figure is the anchor. It is unusually useful because it is an official current average, not just a vague promise of speed.
What the official sources do and do not tell you
The current RNA materials are more explicit than many journals.
They tell you:
- authors can anticipate rapid decisions and publication
- the current average time from submission to final acceptance is 93 days
- the journal has 19 handling editors with broad RNA expertise
- editorial policy is meant to expedite revision and re-review
They do not tell you:
- a public desk-rejection median
- a public first-decision median split from total acceptance time
- a formal breakdown by article type
So the best way to read RNA is to treat the 93-day official number as the center of gravity, then use article histories to remember that real papers still vary.
A practical timeline authors can actually plan around
Stage | Practical expectation | What is happening |
|---|---|---|
Initial editorial assessment | Early in the cycle | Editors decide whether the paper is truly RNA-centered |
First external review round | Often within the first half of the 93-day path | Specialist reviewers judge mechanistic depth and RNA-field relevance |
Revision and re-review | Often focused rather than open-ended | The journal says editors actively work to expedite this stage |
Final acceptance | About 93 days on average from original submission | Clean specialist-fit papers often move efficiently |
Online publication | Often soon after acceptance | RNA markets itself as a rapid publication venue |
That is the author planning model. Most of the time burden sits inside the scientific review path, not in a long production backlog.
Concrete article-history examples
The official average is more useful when paired with actual article histories.
- one 2018 RNA article was received April 27, 2018 and accepted June 26, 2018, about 60 days
- one 2023 RNA article was received November 16, 2022 and accepted April 5, 2023, about 140 days
- one 2020 RNA article was received November 1, 2019 and accepted May 12, 2020, about 193 days
Those examples show the real pattern. RNA can be fast, but the average still hides meaningful spread depending on review difficulty and revision depth.
Why RNA can feel fast
RNA often feels fast because it is a specialist journal with a clear identity.
The journal usually moves cleanly when:
- the paper is unmistakably about RNA biology
- the mechanistic claim is proportional to the evidence
- the main audience is already the RNA field
- the editor can identify the right handling scientist and reviewers quickly
That combination reduces uncertainty at the front end.
What usually slows it down
The slower cases are usually the ones that look RNA-adjacent rather than RNA-centered.
- broader biology papers using RNA as a tool rather than a subject
- transcriptomics-heavy papers with weak RNA-biological mechanism
- methods papers where the general method is stronger than the RNA insight
- manuscripts whose mechanistic claims still depend on one unresolved causal step
Those cases take longer because the journal has to decide whether the paper belongs at all.
Desk timing and what to do while waiting
If the paper has cleared the first pass, the best use of the waiting period is to sharpen the RNA-centeredness of the argument.
- make sure the title and abstract name the RNA-biological problem directly
- tighten any claim that overstates what the mechanism really shows
- prepare a clear answer for why the paper belongs in RNA rather than in NAR, Cell Reports, or a broader molecular-biology venue
- check whether the first figures foreground RNA behavior rather than only a larger system around it
At RNA, waiting well usually means making the RNA argument harder to miss.
Timing context from the journal's citation position
Metric | Value | Why it matters for review time |
|---|---|---|
Impact Factor | 5.0 | The journal is selective inside a specialist lane, not a broad prestige filter |
5-year JIF | 4.7 | Stable citation profile supports a mature editorial process |
Category rank | 70/319 | Respectable Q1 standing without high-glamour bottlenecks |
Total cites | 12,706 | Strong specialist readership, not hyper-broad volume pressure |
That profile helps explain why RNA can be relatively efficient. It is selective, but it is not trying to manage the same prestige congestion as a flagship glamour title.
Longer-run journal trend and what it means for timing
Year | Impact Factor |
|---|---|
2017 | ~4.5 |
2018 | ~4.3 |
2019 | ~4.1 |
2020 | 4.5 |
2021 | 5.1 |
2022 | 4.4 |
2023 | 4.4 |
2024 | 5.0 |
The journal is stable rather than volatile. That usually means the review-time pattern is structural and not being distorted by sudden submission surges or launch-phase behavior.
Directionally, RNA is up from 4.4 in 2023 to 5.0 in 2024 on the JCR side, and the Scopus impact score is up from 3.71 in 2023 to 3.83 in 2024.
Readiness check
While you wait on RNA, scan your next manuscript.
The scan takes 60 seconds. Use the result to decide whether to revise before the decision comes back.
How RNA compares with nearby journals on timing
Journal | Timing signal | Editorial posture |
|---|---|---|
RNA | Official 93-day average to final acceptance | Specialist RNA-biology journal with relatively efficient handling |
Nucleic Acids Research | Broader nucleic-acid lane | Stronger general methods and infrastructure pull |
RNA Biology | Another specialist option with different editorial culture | Broader RNA-adjacent spread |
Molecular Cell | Flagship broader-mechanism lane | Higher editorial threshold and different readership ambition |
This matters because a manuscript that belongs in RNA often moves better there than it would in a broader venue chosen mainly for brand.
What review-time data hides
The timing number still hides a few things:
- the 93-day average is total time to final acceptance, not a first-decision number
- some accepted papers move far faster than average, while others take much longer
- the largest variable is usually fit and mechanistic completeness, not administrative drag
- a paper that is only RNA-heavy, rather than RNA-centered, can lose time because the journal has to resolve a basic ownership question first
In our pre-submission review work with RNA manuscripts
The most common timing mistake is assuming that because RNA is a specialist journal, any manuscript with a lot of RNA data should move smoothly.
That is not how the journal behaves.
The papers that move best here usually have:
- a clearly RNA-centered first-page story
- a mechanistic claim that matches the actual evidence
- a stronger specialist-readership case than broader-journal case
- fewer reasons for the editor to wonder whether the paper really belongs in another venue
Those traits improve timing because they remove ambiguity early.
Submit if / Think twice if
Submit if the manuscript is genuinely about RNA biology itself, the specialist RNA audience is the real audience, and the mechanistic story is already clean enough for technical review.
Think twice if the strongest contribution is broader molecular biology, general methods, or dataset generation with RNA as one layer. In those cases, the problem is usually journal ownership more than raw speed.
What should drive the submission decision instead
For RNA, timing matters, but RNA-centered fit matters more.
That is why the better next reads are:
- RNA submission guide
- RNA impact factor
- How to choose the right journal for your paper
- How pre-submission review works
A specialist RNA fit check is usually more useful than anchoring only on the 93-day average.
Practical verdict
RNA review time is relatively efficient by journal standards, with an official current average of 93 days from submission to final acceptance. But the real speed depends on whether the manuscript is unmistakably RNA-centered and mechanistically mature from the start.
Frequently asked questions
RNA's current publisher materials say the average time from submission to final acceptance is 93 days. That is about 3.1 months and is one of the clearest official timing signals the journal publishes.
The official RNA promotion materials say authors can anticipate rapid decisions and publication, and the journal's article histories show papers being published online shortly after acceptance in many cases.
Because the average includes both cleaner and harder cases. Public article histories show meaningful variation, and the biggest timing variable is whether the manuscript is truly RNA-centered and mechanistically mature for specialist review.
RNA-centered fit is the main variable. Papers that are clearly about RNA biology itself move more cleanly than broader biology papers that mainly use RNA tools or RNA data as one measurement layer.
Sources
- RNA instructions for contributors
- Key advantages to publishing in RNA
- Queuosine modification protects cognate tRNAs against ribonuclease cleavage
- Formamide significantly enhances the efficiency of chemical adenylation of RNA sequencing ligation adaptors
- Influenza A virus utilizes noncanonical cap-snatching to diversify its mRNA/ncRNA
- Resurchify: RNA
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: whether the package is ready, what drives desk rejection, how journals compare, and what the submission requirements look like across journals.
Checklist system / operational asset
Elite Submission Checklist
A flagship pre-submission checklist that turns journal-fit, desk-reject, and package-quality lessons into one operational final-pass audit.
Flagship report / decision support
Desk Rejection Report
A canonical desk-rejection report that organizes the most common editorial failure modes, what they look like, and how to prevent them.
Dataset / reference hub
Journal Intelligence Dataset
A canonical journal dataset that combines selectivity posture, review timing, submission requirements, and Manusights fit signals in one citeable reference asset.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Best next step
Use this page to interpret the status and choose the next sensible move.
For RNA, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.
Guidance first. Use the scan for the next manuscript.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
Use this page to interpret the status and choose the next sensible move.
Guidance first. Use the scan for the next manuscript.